CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset

Annett Maderer (1) , Frederic Fiteni (2, 3, 4) , Erik Tanis (3) , Murielle Mauer (3) , Thomas Schmitt (1) , Daniela E Aust (5) , Manfred P. Lutz , Felicitas Roelofson , Christiane Gog (6) , Arndt Weinmann (1) , Claus Koehne (7) , Markus Moehler (1) , Thomas Thomaidis (1)

1 University Medical Center of the Johannes Gutenberg-University Mainz
2 CHU Nîmes - Centre Hospitalier Universitaire de Nîmes
3 EORTC - European Organisation for Research and Treatment of Cancer [Bruxelles]
4 IDESP - Institut Desbrest de santé publique
5 University Hospital Carl Gustav Carus [Dresden, Germany]
6 Goethe-Universität Frankfurt am Main
7 University of Oldenburg

Domaines: Cancer

Annett Maderer, Frederic Fiteni, Erik Tanis, Murielle Mauer, Thomas Schmitt, et al.. CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset. Acta Oncologica, 2021, 60 (11), pp.1543-1547. ⟨10.1080/0284186X.2021.1959057⟩. ⟨hal-03630670⟩